BSC-CNS Newsletter November 2020

Barcelona Supercomputing Center - Newsletter
NEWSLETTER November 2020

Cutting-edge technologies developed at BSC have allowed the creation of 10 new companies in five years

These companies use results from part of the research and technology developed at the centre to offer cutting-edge services in such diverse areas as biomedicine, aerospace and automobile industries’ security or quantum computing. Spin-offs that have emerged from research carried out at BSC have already created 93 high-skilled job posts, and an investment of 2.5 million euros.

Artificial Intelligence to predict the evolution of patients with COVID-19

The Hospital Clínic de Barcelona and BSC work together to create a model based on artificial intelligence that helps doctors predict the evolution of patients with COVID-19 and those responsible for the centres to plan their internal organization in the event of a new wave. The project is part of the Plan for the Promotion of Language Technologies of the Secretary for Digitalisation and Artificial Intelligence.

An international competition evaluates AI tools to help in the diagnosis of cancer cases

The CANTEMIST international competition has shown the capacity of the new generation of artificial intelligence (AI) tools to extract and catalog clinical information to help doctors carry out more precise diagnostics of cancer cases. The systems generated during this competition could facilitate the automatization of tumor biobanks, as well as clinical reports of tumor pathology.

Improving European healthcare through cell-based interceptive medicine

The LifeTime initiative, including BSC, has developed a strategy to advance personalised treatment for five major disease classes: cancer, neurological-, infectious-, chronic inflammatory- and cardiovascular diseases. The aim is a new age of personalised, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment.

PerMedCoE: Exascale-ready cell-level simulations for European Personalised Medicine

Coordinated by BSC and funded by the European Commission, this recently launched HPC centre of excellence will optimise codes for cell-level simulations in HPC/Exascale and bridge the gap between organ and molecular simulations, thus contributing to the European Personalised Medicine Roadmap.

Timeline of early eukaryotic evolution unveiled

A collaborative study between the groups of Toni Gabaldón, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) and BSC, and Berend Snel at the University of Utrecht, has concluded that the first cell to incorporate a mitochondrion (considered the key step to the increased complexity of eukaryotic cells) already presented eukaryote-like complexity in structure and functions.

BSC experts design a system to alert users to the effects of AI-based applications in a quick way

The objective is that everyone can quickly and intuitively understand under what privacy conditions each service operates, as well as the possible existence of biases in their interaction. The information system proposed by the researchers is based on ethical criteria of privacy and transparency and aims to facilitate users the decision to use or not applications that incorporate AI.

BSC and the Barcelona City Council expand their collaboration

The collaboration is oriented to carry out citizen science projects that need a high capacity of processing from municipal data; promote scientific dissemination; participate in citizen science projects, and facilitate the exchange and circulation of research staff in citizen science projects and city challenges.

Alfonso Valencia, named as the IMI scientific committee vice-chair

The director of the Life Sciences department at BSC, Alfonso Valencia, is now the Innovative Medicines Initiative (IMI) scientific committee’s vice-chair. Valencia has been unanimously elected, as has Isabelle Bekeredjian-Ding, who will be the chair. The IMI is the largest public-private initiative in the world, which aims to improve biomedical research in Europe to achieve safer and more effective medicines in shorter times.

The new Catalan Minister of Business and Knowledge highlights "the strategic role" of BSC in his visit to the centre

Ramon Tremosa highlighted "the strategic role" of BSC as a "search engine for excellence and technology transfer and innovation for the Catalan economy". During the visit, Tremosa reaffirmed the commitment of the Catalan Government to the centre, which will materialize in a contribution of 59 million euros during the period 2020-2029.

The Catalan Minister Meritxell Budó visits BSC

The Minister of the Presidency of the Catalan Government, Meritxell Budó, visited BSC to see first-hand the research that is being carried out. Budó was able to learn about the main projects underway in the centre, such as the development of a new European-made chip. She also saw the progress of the works of the new building that will be the headquarters of BSC, and visited the space under construction that will house the future MareNostrum 5 supercomputer.

Coming up
09 NOV 2020 SC 20 Location: Online
10 NOV 2020 PATC: Earth Sciences Simulation Environments Location: Online
27 NOV 2020 1st Spanish Fusion HPC Workshop Location: Online
Twitter  Facebook  Instagram  LinkedIn  YouTube